Raise closed, search for fresh raises on Seedstage

Irvine, CA

Developing a senolytic immunotherapy to reverse atherosclerosis and extend healthy lifespan.

• Senolytic Approach: Developing a therapy to reverse atherosclerosis and extend healthy lifespan.
• Preclinical Success: Demonstrated plaque prevention and cardiac function restoration in mouse studies.
• Collaborative Research: Initiated collaborations with Wake Forest University for primate studies.
• Patent Protection: Protected technology with a PCT patent application covering multiple aspects.
• Experienced Team: Assembled a cross-disciplinary team with expertise in immunology and aging biology.

Vertical Longevity Pharma is developing a senolytic approach aimed at reversing atherosclerosis, a leading cause of death, and extending healthy lifespan. The company’s platform targets aging at its root, with the potential to treat multiple age-related diseases through a scalable, low-cost immunotherapy. The current fundraising effort is intended to support testing in primates and move toward clinical trials, building on successful preclinical results in mice.

The company has protected its technology with a PCT patent application and has initiated collaborations with institutions like Wake Forest University. Vertical Longevity Pharma’s team includes experts in immunology, aging biology, and regulatory strategy, and they have secured early-stage funding commitments to support their research. The company aims to address the root cause of heart disease by targeting pathogenic cells that accumulate with age, offering a potential new standard of care for cardiovascular health.

Company Info

Vertical Longevity Pharma develops senolytic immunotherapy to reverse atherosclerosis and extend healthy lifespan.

Vertical Longevity Pharma is focused on developing a senolytic immunotherapy aimed at reversing atherosclerosis, a leading cause of death worldwide. The company’s platform targets the root causes of aging, with the potential to treat multiple age-related diseases through a scalable and low-cost approach. By training the immune system to clear out pathogenic cells that accumulate with age, Vertical Longevity Pharma aims to reverse damage and rejuvenate the body naturally.

The company has demonstrated success in preclinical mouse studies and is working towards testing in primates and clinical trials. With a mission-driven team of scientists and experts, Vertical Longevity Pharma is committed to providing durable and affordable therapies that address the cellular drivers of heart disease and other age-related conditions. Their approach is designed to work with the body, offering a new path to recovery and extending healthy lifespan.